Elan's Prialt hits Phase III endpoint.(Thursday, January 8)(Brief Article)

Elan Corp. plc aims to launch its non-opioid peptide-based analgesic Prialt "no later" than the first quarter of 2005, following news that the compound met its primary endpoint in a trial of 220 patients with severe chronic pain who had not obtained relief with other therapies. The Dublin, Ireland-based pharmaceutical company hasn't released the …